KyungDong Pharm Co., Ltd. releases the selective antihistamine 'Beporizine Tablet' on December 26, 2017.
'Beporizine Tablets' is a second-generation antihistamine used for allergic rhinitis and hives by inhibiting the action of histamine, a cause of allergic diseases. The effect of 'Beporizine Tablets' appears quickly within 1 hour after taking, and drowsiness side effects are significantly improved compared to the first generation antihistamine (Diphenhydramine).
In addition, it is released in two strengths, 5mg and 10mg, making it easy to use in combination with other drugs and convenient dosage adjustment.
KyungDong Pharm Co., Ltd.'s launch of 'Beporizine Tablets' is expected to be of great help in improving the symptoms of patients with allergic rhinitis and skin diseases.
|
Product Name |
Beporizine tablets 5mg |
Beporizine tablets 10mg |
|
Ingredient content |
Bepotastine besylate 5mg |
Bepotastine besylate 10mg |
|
Indications |
Perennial allergic rhinitis, chronic urticaria, pruritus associated with skin disease | |
|
Dosage and usage |
For adults, bepotastine besylate is administered orally at a dose of 10 mg twice a day. Additionally, it increases or decreases appropriately depending on age and symptoms. | |
|
Reimbursement Code |
648104010 |
648103980 |
|
Packaging unit |
30 tablets, 300 tablets | |
※ Please refer to the product manual for other details such as precautions for use.